Application 213400
- Type
- NDA
- Sponsor
- EPIZYME INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TAZVERIK | TAZEMETOSTAT HYDROBROMIDE | TABLET;ORAL | 200MG | Yes | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TAZVERIK | TAZEMETOSTAT | Epizyme, Inc. | 7db07b5f-4e22-467c-9c0a-f830b08dbb1d | 2026-04-29 | Warnings, Adverse reactions | TAZVERIK |